Progressive (PGR) Insider Files Form 144 to Sell 1,345 Common Shares
Rhea-AI Filing Summary
Form 144 filed for Progressive Corporation (PGR) reports a proposed sale of 1,345 shares of Common stock through Fidelity Brokerage Services, with an aggregate market value of $337,299.10 and an approximate sale date of 08/22/2025 on the NYSE. The filing states these shares were acquired through restricted stock vesting on 07/25/2025 and were issued as compensation. The filer previously sold three separate blocks of Common shares in the past three months—each of 1,267 shares—generating gross proceeds of $351,985.27, $329,901.46 and $313,633.18 on 05/23/2025, 06/20/2025 and 07/18/2025 respectively. The notice includes the standard signed representation that the seller is unaware of undisclosed material adverse information.
Positive
- Compliance disclosure completed: Form 144 lists acquisition method, broker, share counts, aggregate market value and prior sales details
- Shares acquired as compensation via restricted stock vesting: acquisition date and payment nature are disclosed (07/25/2025, Compensation)
Negative
- None.
Insights
TL;DR: Routine insider sale of vested restricted shares; past monthly sales indicate ongoing liquidity events rather than a single large disposition.
The filing documents a planned sale of 1,345 Common shares acquired via restricted stock vesting on 07/25/2025, to be executed through Fidelity on 08/22/2025. Recent transactional history shows three prior sales of 1,267 shares each across May, June and July 2025 with meaningful gross proceeds per tranche. From an investor perspective, these are disclosed insider transactions required by Rule 144 and Rule 10b5-1 representations are included. There is no information in the filing about any undisclosed operational or financial developments affecting the issuer.
TL;DR: Compliance-focused filing documenting disposition of vested compensation shares; disclosure appears procedurally complete.
The notice specifies acquisition via restricted stock vesting and lists broker, share counts, proceeds and sale dates for recent transactions, satisfying standard disclosure elements. The signer affirms absence of undisclosed material adverse information and references plan adoption/instruction fields though no 10b5-1 plan date is provided. No red flags such as unexplained large divestitures or related-party transfers are present in the provided content.